#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma refractory T-cell lymphoma Gastrooesophageal cancer Transplant rejection Cervix carcinoma Nodal marginal zone B-cell lymphoma Acute myeloid leukaemia (in remission) Acute on chronic liver failure Antithrombin III deficiency Acute myeloid leukaemia refractory Anaplastic large cell lymphoma T- and null-cell types Cognitive disorder Juvenile chronic myelomonocytic leukaemia Malignant melanoma Demyelination More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma – Basic Information Usher’s syndrome – Trials in Disease Netherton’s syndrome – Treatment Fragile X syndrome – Diagnostics Mantle cell lymphoma stage III – Trials in Disease Fabry’s disease – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Basic Information Prader-Willi syndrome – Trials in Disease MELAS syndrome – Diagnostics Aicardi-Goutieres syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Albiglutide Iptacopan Sotrovimab Catequentinib Dihydrochloride Tucidinostat TRONTINEMAB ADS-019 Clonidine Hydrochloride Lovo-A F125/10 Fusidic Acid Stiripentol The-630 Defactinib SC0062 Amcenestrant Rineterkib Fingolimod Hydrochloride Elvn-002-1 Diazepam More therapies…

    Learn about Your Condition

    Device related infection Microvillous inclusion disease Inflammation Implantation complication Immune-mediated enterocolitis Mantle cell lymphoma stage III Enteritis Lung adenocarcinoma stage III Cervix carcinoma stage IV Delayed graft function Perineal injury Short stature Gastric cancer Obsessive-compulsive disorder Malignant glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Specjalistyczny gabinet dermatologiczny Aplikacyjno-Badawczy…

Specjalistyczny gabinet dermatologiczny Aplikacyjno-Badawczy M. Brzewski, P. Brzewski S.C.

Ul. Zbożowa 2/25, Cracow, 30-002, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

    Not recruiting

    3 1
    Investigated Diseases:
    • Alopecia areata
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia France Germany Greece +7

  • Study of Ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Dexamethasone
    Belgium Bulgaria Germany Hungary Italy Poland +2

  • Study on the Effects of Upadacitinib in Adults and Adolescents with Non-Segmental Vitiligo Eligible for Systemic Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria France Germany Hungary Italy +5

  • Study on Abrocitinib for Patients with Moderate to Severe Chronic Hand Eczema Unresponsive to Corticosteroids

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hand dermatitis
    Investigated Drugs:
    • Abrocitinib
    Poland

  • Study on the Effectiveness and Safety of JNJ-77242113 for Treating Plaque Psoriasis in Special Areas for Patients with Moderate to Severe Symptoms

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Jnj-77242113
    Germany Hungary Poland Spain

  • Study on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Jnj-77242113
    France Germany Hungary Italy Poland Spain
Previous Page
1 2 3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!